SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-022979
Filing Date
2022-02-14
Accepted
2022-02-14 16:40:59
Documents
1
Group Members
MICHAEL P. RUBINNORTHPOND VENTURES GP, LLC 2NORTHPOND VENTURES II GP, LLCNORTHPOND VENTURES II, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G tm226606d1_sc13g.htm SC 13G 92350
  Complete submission text file 0001104659-22-022979.txt   94133
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Subject) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93359 | Film No.: 22633441
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7500 OLD GEORGETOWN ROAD SUITE 850 BETHESDA MD 20814
Business Address 7500 OLD GEORGETOWN ROAD SUITE 850 BETHESDA MD 20814 240-800-1200
Northpond Ventures, LP (Filed by) CIK: 0001867472 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G